FEATURED

COVID 19 Articles

Why Tempus AI Skyrocketed This Week

Tempus AI stock surged 39.5% this week following positive Phase 3 trial results for a cancer vaccine developed by Merck and Moderna using technology from Personalis, which Tempus is acquiring.

Trending COVID 19 News

Asylum appeal backlog at record high, new figures show

Asylum appeal backlog at record high, new figures show

While the government has cut the backlog of cases waiting for a decision, the number of appeals has risen. Article Attribution | Read More at Article Source [mwai_chat context="Let's have a discussion about this article:nnWhile the government has cut the backlog of...

read more
Healey resigns as defence secretary amid military spending row

Healey resigns as defence secretary amid military spending row

The cabinet minister says funding for a new defence investment plan "falls well short of what is required". Article Attribution | Read More at Article Source [mwai_chat context="Let's have a discussion about this article:nnThe cabinet minister says funding for a new...

read more